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Sara B. Cullinan1Genomic Privacy in GWAS?
Im et al., page 591
Recent technological advances have made it possible to
interrogate human phenotypes at a previously unimagin-
able scale. But, as with any collection of personal data, it
is important to ensure individual privacy. Indeed, previous
investigations into the ability to discern an individual’s
participation in genetic studies have led to the withdrawal
of allele frequencies from publicly available results. In this
issue, Im et al. probe deeper, questioning how much
private information can be extracted from typically re-
ported statistics, such as regression coefficients or p values.
Through a series of analyses, the authors determine that
regression coefficients can, in some cases, provide just as
much information as allele frequencies, thus creating a
situation in which even statistics that were thought to be
‘‘safe’’ can in fact identify participants and their medical
history. The possibility of membership detection is espe-
cially high in cases in which multiple phenotypes are
being reported, e.g., in multiple-omics data sets. With
exome- and whole-genome sequencing (and the large
data sets that they generate) becoming more common, it
is clear that many additional discussions between scien-
tists, clinicians, and ethicists are needed to ensure that
privacy can be maintained without sacrificing the dissem-
ination of research findings.A Major mtDNA Shake-Up
Behar et al., page 675
In 1981, the revised Cambridge Reference Sequence was
published. It immediately became the standard against
which human mtDNA is compared and phylogenies are
derived. Indeed, its publication enabled a tremendous
amount of research aimed at better understanding human
history.However, the realization that this sequence belongs
to a recently coalescing European haplogroup creates
several concerns about inconsistencies and misinterpreta-
tion. To address these concerns, Behar et al. set out to reas-
sess and refine the human mtDNA phylogeny, and in so
doing, they constructed a new reference mtDNA sequence,
termed the Reconstructed Sapiens Reference Sequence
(RSRS). Generated through the assessment of over 18,000
human mtDNA sequences, as well as those of Homo
neanderthalensis, the RSRS performs well in molecular clock1Deputy Editor, AJHG
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The Amanalyses and lays the groundwork for a new way of ana-
lyzing mtDNA. Although this change will require a large
amount of rethinking, the authors put forth a coherent
plan to make this feasible, including tools to transform
previously generated data and analyses. With the amount
of deep-sequencing data that should become available in
the coming years, the RSRS presents a ‘‘next-generation’’
approach to understanding human matrilineal diversity.First Steps toward Understanding Birth Weight
Ishida et al., page 715
Babies come in many different sizes, but being too small
is a major health concern. Indeed, intrauterine growth
restriction (IUGR) serves as a risk factor for several adult
diseases, including obesity and type 2 diabetes. Although
maternal health plays a large role in directing fetal growth,
the genetic factors that contribute to the variability in fetal
size remain poorly understood. Of interest, however, are
those genes that undergo imprinting, a process by which
the parent of origin determines monoallelic expression.
Evolutionary theory posits that expression of alleles in-
herited from the father promote in utero growth, whereas
those inherited from the mother inhibit growth. But what
happens if the maternally inherited allele exhibits an
altered expression pattern? Might the balance be tipped?
In this issue, Ishida et al. explored the possibility that
variants in PHLDA2, which is only expressed from the
maternal allele, might influence birth weight. Their studies
identified a variant in the PHLDA2 promoter region that
eliminates several consensus transcription factor binding
sites and should therefore lead to decreased expression.
Then, through a cross-sectional study of normal births,
they showed that inheritance of this variant (from the
mother), as well as maternal homozygosity, correlated
with increased birth weight. Future studies, focused specif-
ically on IUGR, should help to elucidate how variation in
PHLDA2, and potentially in other imprinted genes, con-
tributes to the regulation of birth weight and related
complications.Evolutionary History of AD Risk Alleles
Raj et al., page 720
Alzheimer’s disease (AD) is the most common neuro-
degenerative disease, and as of yet, there are no effectiveGenetics. All rights reserved.
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treatments, let alone a cure. Therefore, there is great
interest in better understanding the causes of the disease
from both biochemical and genetic standpoints. The
best-characterized genetic risk factor is the ε4 haplotype
of APOE, which, interestingly, shows evidence of having
undergone positive selection, most likely because of an
effect on an unrelated phenotype. With this in mind, Raj
et al. set out to identify other possible indications of selec-
tion in loci shown to associate with AD susceptibility. They
found such evidence, all in East Asian populations, for
three loci, suggesting that the same selective pressure
might have acted on each. Given that AD is unlikely to
serve in such a role, the authors posited that pathogen
exposure might have been the driving force. Indeed,
many signatures of selection in the human genome are
attributed to interactions with pathogens. Interestingly,
the protein products generated at these loci appear to
belong to the same interaction network. This finding
suggests that additional clues about AD risk might be
found by interrogating other branches of this network.
Although much remains to be learned about the variants
that contribute to AD risk, the study of their evolution,
and possible coevolution, will no doubt yield insights
into the underlying biology of the disease.576 The American Journal of Human Genetics 90, 575–576, April 6, 2X Marks the Spot in Breast Cancer Research
Park et al., page 734
The ubiquitous pink ribbons serve as a reminder that
many women (and some men) are affected by breast
cancer. Although well known, BRCA1 and BRCA2 muta-
tions account for a minority of hereditary cancers. There-
fore, a better understanding of the biology of breast
cancer, along with better screening tests, is sought by
many families. To help achieve these goals, Park et al.
used exome sequencing and identified rare mutations in
XRCC2 that serve as susceptibility factors for familial
breast cancer. XRCC2 is a RAD51 paralog that is required
for efficient homologous recombination (HR); its loss
leads to marked genome instability and aneuploidy.
Future studies aimed at delineating the exact role of
XRCC2 mutations, as well as mutations that lie within
the same pathway, in disease onset and/or progression
should aid in the discovery of new treatment options.
This finding adds to the list of genes whose protein prod-
ucts perform crucial roles in HR and whose mutations can
influence breast cancer risk. It also provides support for
those who seek to better understand common diseases
through sequencing studies.012
